Monte Rosa Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Provided By GlobeNewswire
Last update: Jan 6, 2025
BOSTON, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced that Markus Warmuth, M.D., Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 5:15 p.m. PST.
Read more at globenewswire.com
